APA Guidelines Bundle

Borderline Personality Disorder

APA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1532038

Contents of this Issue

Navigation

Page 6 of 9

7 Psychosocial Interventions Statement 5 - Psychotherapy   ➤ APA recommends (1B) that a patient with BPD be treated with a structured approach to psychotherapy that has support in the literature and targets the core features of the disorder. Pharmacotherapy Statement 6 – Clinical Review Before Medication Initiation   ➤ APA recommends (1C) that a patient with BPD have a review of co- occurring disorders, prior psychotherapies, other nonpharmacological treatments, past medication trials, and current medications before initiating any new medication. Statement 7 – Pharmacotherapy Principles   ➤ APA suggests (2C) that any psychotropic medication treatment of BPD be time-limited, aimed at addressing a specific measurable target symptom, and adjunctive to psychotherapy. Statement 8 – Pharmacotherapy Review   ➤ APA recommends (1C) that a patient with BPD receive a review and reconciliation of their medications at least every 6 months to assess the effectiveness of treatment and identify medications that warrant tapering or discontinuation. Treatment

Articles in this issue

Archives of this issue

view archives of APA Guidelines Bundle - Borderline Personality Disorder